Intracellular and extracellular serpins modulate lung disease

被引：20

作者：

Askew, D. J. ^{[1
]}

Silverman, G. A.

机构：

[1] Univ Pittsburgh, Sch Med, Magee Womens Res Inst, Pittsburgh, PA 15213 USA

来源：

JOURNAL OF PERINATOLOGY | 2008年 / 28卷 / Suppl 3期

关键词：

D O I：

10.1038/jp.2008.150

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

An imbalance between peptidases and their inhibitors leads to pulmonary disease. Imbalances occur in the adult and the neonate at risk for a specific set of lung pathologies. Serpins (serine peptidase inhibitors) make up the major source of antipeptidase activity in the lung. The purpose of this review is to describe the serpin mechanism of inhibition, their roles in the normal and pathological lung and their potential as therapeutic agents.

引用

页码：S127 / S135

页数：9

共 109 条

[1] Imbalance between cysteine proteases and inhibitors in a baboon model of bronchopulmonary dysplasia [J].

Altiok, O ;

Yasumatsu, R ;

Bingol-Karakoc, G ;

Riese, RJ ;

Stahlman, MT ;

Dwyer, W ;

Pierce, RA ;

Bromme, D ;

Weber, E ;

Cataltepe, S .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2006, 173 (03) :318-326

[2] SERPINB12 is a novel member of the human ov-serpin family that is widely expressed and inhibits trypsin-like serine proteinases [J].

Askew, YS ;

Pak, SC ;

Luke, CJ ;

Askew, DJ ;

Cataltepe, S ;

Mills, DR ;

Kato, H ;

Lehoczky, J ;

Dewar, K ;

Birren, B ;

Silverman, GA .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (52) :49320-49330

[3] Antithrombin III (ATIII) replacement therapy in patients with sepsis and/or postsurgical complications: a controlled double-blind, randomized, multicenter study [J].

Baudo, F ;

Caimi, TM ;

de Cataldo, F ;

Ravizza, A ;

Arlati, S ;

Casella, G ;

Carugo, D ;

Palareti, G ;

Legnani, C ;

Ridolfi, L ;

Rossi, R ;

D'Angelo, A ;

Crippa, L ;

Giudici, D ;

Gallioli, G ;

Wolfler, A ;

Calori, G .

INTENSIVE CARE MEDICINE, 1998, 24 (04) :336-342

[4] Is protein C inhibitor antithrombotic and protective in pulmonary hypertension? [J].

Beaulieu, L. M. ;

Church, F. C. .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (11) :2327-2330

[5] The granzyme B inhibitor, protease inhibitor 9, is mainly expressed by dendritic cells and at immune-privileged sites [J].

Bladergroen, BA ;

Strik, MCM ;

Bovenschen, N ;

van Berkum, O ;

Scheffer, GL ;

Meijer, CJLM ;

Hack, CE ;

Kummer, JA .

JOURNAL OF IMMUNOLOGY, 2001, 166 (05) :3218-3225

[6] Revisiting α1-antitrypsin therapy in cystic fibrosis:: can it still offer promise? [J].

Brennan, S. .

EUROPEAN RESPIRATORY JOURNAL, 2007, 29 (02) :229-230

[7] Chemical chaperones mediate increased secretion of mutant α1-antitrypsin (α1-AT) Z:: A potential pharmacological strategy for prevention of liver injury and emphysema in α1-AT deficiency [J].

Burrows, JAJ ;

Willis, LK ;

Perlmutter, DH .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (04) :1796-1801

[8] Aerosolized prolastin suppresses bacterial proliferation in a model of chronic Pseudomonas aeruginosa lung infection [J].

Cantin, AM ;

Woods, DE .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 160 (04) :1130-1135

[9] Mechanisms of disease -: Alpha1-antitrypsin deficiency -: A model for conformational diseases [J].

Carrell, RW ;

Lomas, DA .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (01) :45-53

[10] ALPHA-1-ANTITRYPSIN - MOLECULAR PATHOLOGY, LEUKOCYTES, AND TISSUE-DAMAGE [J].

CARRELL, RW .

JOURNAL OF CLINICAL INVESTIGATION, 1986, 78 (06) :1427-1431

← 1 2 3 4 5 6 7 8 9 10 →